Cargando…

Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19

The novel coronavirus disease 2019 (COVID-19) belongs to coronaviridae families like sarbecovirus (SARS), and causes pyrexia, pertussis, and acute respiratory distress syndrome (ARDS) in major. Started from Wuhan, China, COVID-19 now forced the World Health Organization (WHO) call it a global pandem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khodavirdipour, Amir, Piri, Motahareh, Jabbari, Sarvin, Khalaj-kondori, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7964257/ https://www.ncbi.nlm.nih.gov/pubmed/33748818 http://dx.doi.org/10.1055/s-0041-1723086

Ejemplares similares

Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance
por: Khodavirdipour, Amir, et al.
Publicado: (2021)

Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
por: Zhou, Qianqian, et al.
Publicado: (2022)

CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics
por: Kumar, Prashant, et al.
Publicado: (2020)

CRISPR/Cas13: A potential therapeutic option of COVID-19
por: Lotfi, Melika, et al.
Publicado: (2020)

CRISPR/Cas as a Potential Diagnosis Technique for COVID-19
por: Dara, Mahintaj, et al.
Publicado: (2020)

Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis
por: MacGregor, Skye R., et al.
Publicado: (2023)

Targeted gene silencing in the nervous system with CRISPR-Cas13
por: Powell, Jackson E., et al.
Publicado: (2022)

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
por: He, Xuesong, et al.
Publicado: (2022)

Inclusion of Cephalexin in COVID-19 Treatment Combinations May Prevent Lung Involvement in Mild Infections: A Case Report with Pharmacological Genomics Perspective
por: Khodavirdipour, Amir
Publicado: (2021)

CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
por: Quansah, Elvis, et al.
Publicado: (2023)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Composition and Diversity of CRISPR-Cas13a Systems in the Genus Leptotrichia
por: Watanabe, Shinya, et al.
Publicado: (2019)

CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
por: Rajan, Aishwarya, et al.
Publicado: (2022)

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
por: Li, Ruiting, et al.
Publicado: (2022)

Potential Use of CRISPR/Cas13 Machinery in Understanding Virus–Host Interaction
por: Bayoumi, Mahmoud, et al.
Publicado: (2021)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections
por: Qian, Yizheng, et al.
Publicado: (2023)

Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13
por: Marqués, María-Carmen, et al.
Publicado: (2022)

Amplification-free RNA detection with CRISPR–Cas13
por: Shinoda, Hajime, et al.
Publicado: (2021)

The Effect of Beta-Boswellic Acid on the Expression of Camk4 and Camk2α Genes in the PC12 Cell Line
por: Jebelli, Asiyeh, et al.
Publicado: (2020)

RNA virus interference via CRISPR/Cas13a system in plants
por: Aman, Rashid, et al.
Publicado: (2018)

Protocol for Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 System
por: Wang, Yang, et al.
Publicado: (2020)

CRISPR-Cas13a system: a novel approach to precision oncology
por: Zhang, Junxia, et al.
Publicado: (2020)

Corrigendum: Composition and Diversity of CRISPR-Cas13a Systems in the Genus Leptotrichia
por: Watanabe, Shinya, et al.
Publicado: (2020)

Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System
por: Nguyen, Hoang, et al.
Publicado: (2021)

CRISPR-Cas13a system: A novel tool for molecular diagnostics
por: Zhao, Lixin, et al.
Publicado: (2022)

Collateral activity of the CRISPR/RfxCas13d system in human cells
por: Shi, Peiguo, et al.
Publicado: (2023)

Universal theranostic CRISPR/Cas13a RNA-editing system for glioma
por: Wu, Ye, et al.
Publicado: (2023)

Effects of KISS1 structural polymorphism on the risk of polycystic ovary syndrome and reproductive hormones in Iraqi women who take metformin
por: Kadhem, Ali Hakem, et al.
Publicado: (2023)

Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management
por: Karimpur Zahmatkesh, Arezu, et al.
Publicado: (2023)

Editorial: The CRISPR/Cas System in Pathogen Resistance, Virulence, Diagnosis and Typing
por: Duan, Guangcai, et al.
Publicado: (2022)

Nanotechnology Powered CRISPR-Cas Systems for Point of Care Diagnosis and Therapeutic
por: Li, Chen-zhong, et al.
Publicado: (2022)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

CRISPR/Cas13d-Mediated Microbial RNA Knockdown
por: Zhang, Kun, et al.
Publicado: (2020)

CRISPR-Cas13a Inhibits HIV-1 Infection
por: Yin, Lijuan, et al.
Publicado: (2020)

Applications of CRISPR/Cas13-Based RNA Editing in Plants
por: Kavuri, Naga Rajitha, et al.
Publicado: (2022)

Highly multiplexed mRNA quantitation with CRISPR-Cas13
por: Kang, Brian, et al.
Publicado: (2023)

Optimized CRISPR-RfxCas13d system for RNA targeting in zebrafish embryos
por: Hernandez-Huertas, Luis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cg41gi4337au99aolmlnncmf4n